Dividend-News

'Safer' Dividend Healthcare Dog's 55% Top Gain Equals Sum Of Four Tailing It In May

Published Mon, 22 May 2017 18:59:27 -0400 on Seeking Alpha

Actionable Conclusions (1-10): Analysts Augur Top Ten Healthcare "Safer" Dog Stocks to Net 2.57% to 55.34% Gains To May, 2018
Eight of the ten top dividend Healthcare dogs (shaded in the chart above) were verified as being among the top ten yielders for the coming year. Based on analyst 1 year target prices, the dog strategy for this Health group as graded by analyst estimates for May proved 80% accurate.
Ten probable profit generating trades were illustrated by YCharts analytics for 2018:
Psychemedics (PMD) netted $553.36 based on an estimate from one analyst, plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 10% less than the market as a whole.
Pfizer (PFE) netted $183.23 based on dividends plus median target price estimate from twenty-three analysts less broker fees. The Beta number showed this estimate subject to volatility 1% less than the market as a whole.
GlaxoSmithKline (GSK) netted $137.82 based on estimates from six analysts, plus dividends less broker fees. The Beta number showed this estimate subject to volatility 2% less than the market as a whole.
AbbVie (ABBV) netted $128.23 based on mean target price estimates from twenty-two analysts plus dividends less broker fees. The Beta number showed this estimate subject to volatility 54% more than the market as a whole.
Merck & Co (MRK) netted $109.84 based on estimates from twenty-two analysts plus dividends less broker fees. The Beta number... Read more